News tagged with 'Diabetes Drugs'

New research presented at the American Association of Diabetes conference this week suggests blood glucose and insulin sensitivity begins changing several years before the onset of diabetes.

Pfizer has paid $750 million to resolve 35,000 claims over its diabetes drug Rezulin which was withdrawn in 2000 after it was linked to 63 or more deaths from liver damage.

A British analysis finds Avandia and Actos, widely prescribed for type 32 diabetes, doubles the risk of fractures in women (not men). The drugs have already been in the news because of concerns about the risk for heart failure. Women should consider other options, says researchers. 

Families dealing with diabetes, which affects about 1 in 500 under age 20, are challenging school policies that make it hard to test blood sugar and inject insulin at school.

Researchers at Johns Hopkins suggest metformin, also known as Glucophage, appears to be associated with a decrease in heart disease and other heart-related deaths despite controversy surround the diabetes drug Avandia.

A new class of diabetes drugs has shown promising results in a clinical trial conducted to help bring it to market. If approved, liraglutide would be the second GLP-1 diabetes medicine approved by the FDA for sale in the U.S. Byetta was the first.

Just as our nation has skyrocketing obesity rates, the number of diabetic mothers has doubled and increased five fold among teenage mothers, raising the risk for miscarriage, stillbirth and birth defects.

Avandia, a drug to treat Type 2 diabetes, will have to carry a black box warning telling consumers about an increased risk of heart attack. Dissent within the FDA exists, but the agency will let the drug stay on the market.

The FDA Chooses Avandia Over Patients Updated August 2007: The FDA has known of the risk of heart failure associated with Avandia , a type 2 diabetes medicine, for years. Even before the drug was approved, researchers mentioned that there was a risk of cardiovascular illness. But the

Avandia to Stay, says FDA Panel Updated August 2007: A federal drug advisory committee voted 22 to 1 on July 30 that GlaxoSmithKline’s Avandia should remain on the market; although the committee also voted 20 to 3 that the diabetes drug raises the risk of heart attack. Committee members de

July 30 th FDA Meeting to Discuss Avandia Updated July 2007: On July 30, 2007, the FDA will meet with GlaxoSmithKline to discuss the diabetes drug Avandia . The fact-gathering meeting is intended to thrash out the issue of increased heart attack risk for users from the drug. The FDA

Older Diabetes Drugs Work as Well as Avandia Older, cheaper diabetes drugs appear to work as well as Avandia, resolved an analysis on the efficacy of metformin and Avandia , which has recently come under close scrutiny for its ties to heart problems. Between the two, the clear winner is

Updated June, 2007: At the American Diabetes Association ’s annual meeting in Chicago, experts on Avandia debated recent findings about the drug from a study published in the New England Journal of Medicine. The findings show that Avandia users have a 43% increased risk for heart attacks and

Avandia Warnings Ignored by FDA Avandia , a drug for patients with diabetes, was approved on May 25, 1999. The drug was approved because it was shown to be effective in reducing blood sugar levels. Even before the drug was approved, however, there were warnings that revealed that the drug may increase the

West Virginia's state Supreme Court granted class-action status last week to 5,000 lawsuits filed over the recalled diabetes medication Rezulin. Reversing a decision made in 2001 by Raleigh County Judge John A. Hutchison, the high court concluded that class certification should have been granted two years ago based on